Abstract
Amiodarone is effective in maintaining sinus rhythm in atrial fibrillation but is associated with potentially serious toxic effects. Dronedarone is a new antiarrhythmic agent pharmacologically related to amiodarone but developed to reduce the risk of side effects.
Cite
CITATION STYLE
APA
Singh, B. N., Connolly, S. J., Crijns, H. J. G. M., Roy, D., Kowey, P. R., Capucci, A., … Hohnloser, S. H. (2007). Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter. New England Journal of Medicine, 357(10), 987–999. https://doi.org/10.1056/nejmoa054686
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free